Panel Discussion: Burgeoning Applications of Digital Measures in Clinical Development: Opportunities around Stratification, Classification & Label Expansion

Tue, Nov 3, 2026 · 11:35 AM–12:05 PM EST Pfizer Innovation Research Lab

About this session

Digital phenotyping to standardize patient categorization, reduce cohort heterogeneity, and optimize trial population selection; tracking subtle disease trajectories and detecting early-stage shifts to capture changes in progression missed by episodic clinical scales; opportunities to deliver more value to patients and achieve label expansion.

Speakers

Phil Murphy

Head of Imaging & Digital Health · Johnson & Johnson Innovative Medicine

Moderator
Daniel Karlin

Chief Medical Officer · Definium Therapeutics

Panelist
Seemi Kazmi

Global Head of Digital Health · Bristol Myers Squibb

Panelist
Matteo Lai

CEO · Empatica

Panelist
Bhaskar Dutta

Head, Digital Health and Medical Affairs Technologies · Alexion Pharmaceuticals

Panelist